2022 Integrated Annual Report - Global
Skip to main content
Ipsen Home Page
Press shift tab to select search category

Loading...
  • Media  arrow down
    < Back
    • Press Releases
    • Media Statements
    • Media Library
    • Our 2023 Integrated Annual Report is live!

      Featured Image
  • Investors arrow down
      < Back
    • Investors
    • Investors
    • Financial Results
    • Annual Reports and Accounts
    • Presentations
    • Corporate News
    • Financial Calendar
    • Investor Events
    • Shareholder Information
    • Share-Price Data
    • Regulated Information
    • Key Contacts
  • Partnering
  • Careers arrow down
      < Back
    • Careers
    • Careers – 2
    • Working at Ipsen
    • Culture
  • Press shift tab to select search category

    Loading...
  • English  EN     Français  FR     EN  arrow_down
    • English EN
    • Français FR
  • Global Global
    < Back
    • Global EN FR
    • Annual Report EN FR
    • Americas
    • Asia Pacific
    • Europe
    • Middle East & Africa
    • United States
    • Brazil
    • Canada
    • Mexico
    • Australia
    • China
    • Singapore
    • South Korea
    • Japan
    • Belgium
    • Ukraine
    • UK
    • Germany
    • France
    • Nordics
    • Greece
    • Italy
    • Netherlands
    • Spain
    • Poland
    • Russia
    • Czech Republic
    • Austria
    • Switzerland
    • UAE & Gulf
  • Home
  • Company
      < Back
    • Company
    • Company
    • Leadership
        < Back
      • Company
      • History
      • Fondation Ipsen
  • Science
      < Back
    • Science
    • Science
    • Oncology
    • Rare Disease
    • Neuroscience
    • Products
    • R&D
        < Back
      • Science
      • Pipeline
    • Clinical Trials
  • Responsibility
      < Back
    • Responsibility
    • Responsibility
    • Environment
    • Patients
    • People
    • Governance
    • Our Standards
  • Patients
      < Back
    • Patients
    • Patients
    • Together for Oncology
    • Together for Rare Disease
    • Together for Neuroscience
    • Lay Summaries
    • Collaborate with us
  • Stories
  • New Home Page
Back

Post navigation

Previous
Next

2022 Integrated Annual Report

In 2022 we further accelerated Ipsen’s momentum, sustained our growth and made a positive impact for patients and society.

2022 Integrated Annual Report

- 31 May 2023 - 1 mins read

In 2022 we further accelerated Ipsen’s momentum, sustained our growth and made a positive impact for patients and society.

Post navigation

Previous
Next

Share this on social media

  • Share on LinkedIn
  • Share on Facebook

Related Documents

  • Download Integrated Annual Report   Download  (7 MB)

Related Reports and Accounts

Information relating to compensation elements of Mr. David Loew, CEO – 31 May 2023
02 June 2023 0 mins read

Information relating to compensation elements of Mr. David Loew, CEO – 31 May 2023

Compensation policy for corporate officers Combined shareholders’ meeting of 31 May 2023
01 June 2023 0 mins read

Compensation policy for corporate officers Combined shareholders’ meeting of 31 May 2023

2022 Universal Registration Document
06 April 2023 1 mins read

2022 Universal Registration Document

Information relating to the compensation elements of Mr. David LOEW, Chief Executive Officer
09 February 2023 0 mins read

Information relating to the compensation elements of Mr. David LOEW, Chief Executive Officer

2021 Integrated Annual Report
31 May 2022 0 mins read

2021 Integrated Annual Report

Information relating to compensation elements
25 May 2022 0 mins read

Information relating to compensation elements

Compensation policy for corporate officers, result of vote SM
25 May 2022 0 mins read

Compensation policy for corporate officers, result of vote SM

2021 Universal Registration Document
14 April 2022 0 mins read

2021 Universal Registration Document

Information relating to compensation elements
28 May 2021 0 mins read

Information relating to compensation elements

Compensation policy for corporate officers, result of vote SM
28 May 2021 0 mins read

Compensation policy for corporate officers, result of vote SM

IPN price

€103.00

 €-0.70 (-0.68%)

  • Terms and Conditions
  • Cookie Policy
  • Global Privacy Policy
  • Company
  • Responsibility
  • Patients
  • Stories
  • Annual Report
  • Contact us

Ipsen logo
LinkedIn Instagram Facebook Youtube
  • Terms and Conditions
  • Cookie Policy
  • Global Privacy Policy

Copyright © Ipsen Pharma. All rights reserved - 2024

You are now leaving the Ipsen group website.
To continue, please click on Continue?

Continue
This site is registered on wpml.org as a development site. Switch to a production site key to remove this banner.